How Life Sciences Companies are Re-Engaging
With Customers in the COVID-19 Era



Guidehouse has been at the forefront of navigating the coronavirus pandemic’s historic disruption to the commercial operations of pharma-related industries. 

The firm’s work has spanned numerous challenges, as varied as altering commercial practices amid a remote work environment, maintaining an engaged field force, and implementing ongoing compliance considerations.

Join Guidehouse in this conversation to learn how pharmaceutical companies can refine their plans to re-engage with customers - both in the current environment and when restrictions begin to ease.

The discussion will focus on:

  • How COVID-19 has changed product launches.

  • Re-engaging customer - new perspectives and increasing role of data analytics & artificial intelligence.

  • What might lie ahead — during and after the pandemic.

Mark Stevens, Life Sciences Partner at Guidehouse
Nisha Ninan, Managing Consultant at Guidehouse
William Woywod, Managing Consultant at Guidehouse
Stephanie Baum, Director of Special Projects at MedCity News

By filling out this form you are opting in to receive communications from MedCity News and its partners.